Skip to main content
Top
Published in: Insights into Imaging 3/2013

Open Access 01-06-2013 | Original Article

Diffusion weighted MRI in chronic viral hepatitis: correlation between ADC values and histopathological scores

Authors: Mehmet Ruhi Onur, Ahmet Kursad Poyraz, Pinar Gundogan Bozdag, Semen Onder, Cem Aygun

Published in: Insights into Imaging | Issue 3/2013

Login to get access

Abstract

Objective

To investigate the utility of apparent diffusion coefficient (ADC) measurement in the diagnosis of chronic viral hepatitis (CVH) and correlation between ADC values and histopathologic severity of CVH.

Materials and methods

The ADC values of liver parenchyma on diffusion-weighted magnetic resonance imaging (DWMRI) were measured in 50 patients with a history of CVH and 51 healthy subjects at b 100, b 600 and b 1,000 gradients. Comparison between mean ADC values of the CVH and control groups and correlation results between ADC values and necroinflammation and fibrosis scores in CVH were obtained.

Results

Mean ADC values of CVH patients were significantly lower than mean ADC values of the control group at b 100 and b 600 gradients (P < 0.05). There was no significant difference between the CVH and control groups at the b 1,000 gradient (P > 0.05). No significant correlation was found between ADC values and histopathologic scores of CVH (P > 0.05).

Conclusion

ADC values obtained at the b 100 and b 600 gradients can be used to distinguish between the liver parenchyma of CVH and healthy subjects. ADC measurement was not found to be useful for estimation of the degree of necroinflammation and fibrosis in CVH.

Teaching Points

In chronic viral hepatitis apparent coefficient values are decreased in the liver
There is no correlation between ADC values and histopathologic severity of CVH
DW images obtained at low b values have more ability to demonstrate an ADC decrease in viral hepatitis
Literature
1.
go back to reference Afdhal NH, Nunes D (2004) Evaluation of liver fibrosis: a concise review. Am J Gastroenterol 99:1160–1174PubMedCrossRef Afdhal NH, Nunes D (2004) Evaluation of liver fibrosis: a concise review. Am J Gastroenterol 99:1160–1174PubMedCrossRef
2.
go back to reference Lawrence SP (2000) Advances in the treatment of hepatitis C. Adv Intern Med 45:65–105PubMed Lawrence SP (2000) Advances in the treatment of hepatitis C. Adv Intern Med 45:65–105PubMed
3.
go back to reference Buti M, San Miguel R, Brosa M, Cabases JM, Medina M, Angel Casado M et al (2005) Estimating the impact of hepatitis C virus therapy on future liver-related morbidity, mortality and costs related to chronic hepatitis C. J Hepatol 42:639–645PubMedCrossRef Buti M, San Miguel R, Brosa M, Cabases JM, Medina M, Angel Casado M et al (2005) Estimating the impact of hepatitis C virus therapy on future liver-related morbidity, mortality and costs related to chronic hepatitis C. J Hepatol 42:639–645PubMedCrossRef
4.
go back to reference Wong JB, Bennet WG, Koff RS, Pauker SG (1998) Pretreatment evaluation ofchronic hepatitis C: risks, benefits, and costs. JAMA 280:2088–2093PubMedCrossRef Wong JB, Bennet WG, Koff RS, Pauker SG (1998) Pretreatment evaluation ofchronic hepatitis C: risks, benefits, and costs. JAMA 280:2088–2093PubMedCrossRef
6.
go back to reference Girometti R, Furlan A, Bazzocchi M, Soldano F, Isola M, Toniutto P et al (2007) Diffusion-weighted MRI in evaluating liver fibrosis: a feasibility study in cirrhotic patients. Radiol Med 112(3):394–408PubMedCrossRef Girometti R, Furlan A, Bazzocchi M, Soldano F, Isola M, Toniutto P et al (2007) Diffusion-weighted MRI in evaluating liver fibrosis: a feasibility study in cirrhotic patients. Radiol Med 112(3):394–408PubMedCrossRef
7.
go back to reference Koinuma M, Ohashi I, Hanafusa K, Shibuya H (2005) Apparent diffusion coefficient measurements with diffusion-weighted magnetic resonance imaging for evaluation of hepatic fibrosis. J Magn Reson Imaging 22(1):80–85PubMedCrossRef Koinuma M, Ohashi I, Hanafusa K, Shibuya H (2005) Apparent diffusion coefficient measurements with diffusion-weighted magnetic resonance imaging for evaluation of hepatic fibrosis. J Magn Reson Imaging 22(1):80–85PubMedCrossRef
8.
go back to reference Boulanger Y, Amara M, Lepanto L, Beaudoin G, Nguyen BN, Allaire G et al (2003) Diffusion-weighted MR imaging of the liver of hepatitis C patients. NMR Biomed 16:132–136PubMedCrossRef Boulanger Y, Amara M, Lepanto L, Beaudoin G, Nguyen BN, Allaire G et al (2003) Diffusion-weighted MR imaging of the liver of hepatitis C patients. NMR Biomed 16:132–136PubMedCrossRef
9.
go back to reference Lewin M, Poujol-Robert A, Boëlle PY, Wendum D, Lasnier E, Viallon M et al (2007) Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C. Hepatology 46:658–665PubMedCrossRef Lewin M, Poujol-Robert A, Boëlle PY, Wendum D, Lasnier E, Viallon M et al (2007) Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C. Hepatology 46:658–665PubMedCrossRef
10.
go back to reference Theise ND (2007) Liver biopsy assessment in chronic viral hepatitis: a personal, practical approach. Mod Pathol 20(Suppl 1):S3–S14PubMedCrossRef Theise ND (2007) Liver biopsy assessment in chronic viral hepatitis: a personal, practical approach. Mod Pathol 20(Suppl 1):S3–S14PubMedCrossRef
11.
go back to reference Vermoolen MA, Kwee TC (2012) Nievelstein RA (2012) Apparent diffusion coefficient measurements in the differentiation between benign and malignant lesions: a systematic review. Insights Imaging 3(4):395–409PubMedPubMedCentralCrossRef Vermoolen MA, Kwee TC (2012) Nievelstein RA (2012) Apparent diffusion coefficient measurements in the differentiation between benign and malignant lesions: a systematic review. Insights Imaging 3(4):395–409PubMedPubMedCentralCrossRef
12.
go back to reference Taouli B, Chouli M, Martin AJ, Qayyum A, Coakley FV, Vilgrain V (2008) Chronic hepatitis: role of diffusion-weighted imaging and diffusion tensor imaging for the diagnosis of liver fibrosis and inflammation. J Magn Reson Imaging 28(1):89–95PubMedCrossRef Taouli B, Chouli M, Martin AJ, Qayyum A, Coakley FV, Vilgrain V (2008) Chronic hepatitis: role of diffusion-weighted imaging and diffusion tensor imaging for the diagnosis of liver fibrosis and inflammation. J Magn Reson Imaging 28(1):89–95PubMedCrossRef
13.
go back to reference Annet L, Materne R, Danse E, Jamart J, Horsmans Y, Van Beers BE (2003) Hepatic flow parameters measured with MR imaging and Doppler US:correlations with degree of cirrhosis and portal hypertension. Radiology 229:409–414PubMedCrossRef Annet L, Materne R, Danse E, Jamart J, Horsmans Y, Van Beers BE (2003) Hepatic flow parameters measured with MR imaging and Doppler US:correlations with degree of cirrhosis and portal hypertension. Radiology 229:409–414PubMedCrossRef
14.
go back to reference Annet L, Peeters F, Abarca-Quinones J, Leclercq I, Moulin P, Van Beers BE (2007) Assessment of diffusion-weighted MR imaging in liver fibrosis. J Magn Reson Imaging 25:122–128PubMedCrossRef Annet L, Peeters F, Abarca-Quinones J, Leclercq I, Moulin P, Van Beers BE (2007) Assessment of diffusion-weighted MR imaging in liver fibrosis. J Magn Reson Imaging 25:122–128PubMedCrossRef
15.
go back to reference Yang ZH, Ye XH, Tan Y, Zhang M, Zhou MZ, Xie JX et al (2006) Evaluation of cirrhotic liver with perfusion-weighted magnetic resonance imaging: a preliminary experimental study in animal models with half-liver cirrhosis. Chin Med Sci J 21:252–257PubMed Yang ZH, Ye XH, Tan Y, Zhang M, Zhou MZ, Xie JX et al (2006) Evaluation of cirrhotic liver with perfusion-weighted magnetic resonance imaging: a preliminary experimental study in animal models with half-liver cirrhosis. Chin Med Sci J 21:252–257PubMed
16.
go back to reference Luciani A, Vignaud A, Cavet M, Nhieu JT, Mallat A, Ruel L et al (2008) Liver cirrhosis: intravoxel incoherent motion MR imaging—pilot study. Radiology 249:891–899PubMedCrossRef Luciani A, Vignaud A, Cavet M, Nhieu JT, Mallat A, Ruel L et al (2008) Liver cirrhosis: intravoxel incoherent motion MR imaging—pilot study. Radiology 249:891–899PubMedCrossRef
17.
go back to reference Soylu A, Kiliçkesmez O, Poturoğlu S, Dolapçioğlu C, Serez K, Sevindir I et al (2010) Utility of diffusion-weighted MRI for assessing liver fibrosis in patients with chronic active hepatitis. Diagn Interv Radiol 16(3):204–208PubMed Soylu A, Kiliçkesmez O, Poturoğlu S, Dolapçioğlu C, Serez K, Sevindir I et al (2010) Utility of diffusion-weighted MRI for assessing liver fibrosis in patients with chronic active hepatitis. Diagn Interv Radiol 16(3):204–208PubMed
18.
go back to reference Sandrasegaran K, Akisik FM, Lin C, Tahir B, Rajan J, Saxena R et al (2009) Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis. AJR Am J Roentgenol 193(6):1556–1560PubMedCrossRef Sandrasegaran K, Akisik FM, Lin C, Tahir B, Rajan J, Saxena R et al (2009) Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis. AJR Am J Roentgenol 193(6):1556–1560PubMedCrossRef
19.
go back to reference Chandarana H, Taouli B (2010) Diffusion and perfusion imaging of the liver. Eur J Radiol 76(3):348–358PubMedCrossRef Chandarana H, Taouli B (2010) Diffusion and perfusion imaging of the liver. Eur J Radiol 76(3):348–358PubMedCrossRef
20.
go back to reference Guiu B, Cercueil JP (2011) Liver diffusion-weighted MR imaging: the Tower of Babel? Eur Radiol 21(3):463–467PubMedCrossRef Guiu B, Cercueil JP (2011) Liver diffusion-weighted MR imaging: the Tower of Babel? Eur Radiol 21(3):463–467PubMedCrossRef
Metadata
Title
Diffusion weighted MRI in chronic viral hepatitis: correlation between ADC values and histopathological scores
Authors
Mehmet Ruhi Onur
Ahmet Kursad Poyraz
Pinar Gundogan Bozdag
Semen Onder
Cem Aygun
Publication date
01-06-2013
Publisher
Springer Berlin Heidelberg
Published in
Insights into Imaging / Issue 3/2013
Electronic ISSN: 1869-4101
DOI
https://doi.org/10.1007/s13244-013-0252-x

Other articles of this Issue 3/2013

Insights into Imaging 3/2013 Go to the issue